Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 340780Generated: October 29, 2026

Tetrabutylammonium Fluoride → 3-{[5-(biphenyl-4-yl)-6-chloro-1H-benzimidazol-2-yl]oxy}cyclopentane carboxylic acid

https://huagongshe.com/reaction/340780

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTetrabutylammonium FluorideHCID 2724141—
ReactantEthyl 3-{[5-(biphenyl-4-yl)-6-chloro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-benzimidazol-2-yl]oxy}cyclopentanecarboxylateHCID 71074041—
SolventTetrahydrofuranHCID 8028—
Product3-{[5-(biphenyl-4-yl)-6-chloro-1H-benzimidazol-2-yl]oxy}cyclopentane carboxylic acidHCID 53372118—

Reaction Conditions

Temperature80 °C

Reaction Steps

To a solution of ethyl 3-{[5-(biphenyl-4-yl)-6-chloro-1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-benzimidazol-2-yl]oxy}cyclopentanecarboxylate (80 mg, 0.135 mmol) in 2.7 mL of THF was added TBAF (0.700 mL, 0.700 mmol) dropwise via syringe. The reaction was heated at 80° C. for 1.5 h. After heating for 4 h, the reaction was concentrated and the residue was re-dissolved in 4 mL of MeOH and treated with 1 mL of 2.5 N NaOH. The reaction was maintained at ambient temperature overnight. Then the solvent was removed and the resulting residue was dissolved in H2O and acidified to pH 1 with 2 N HCl. The aqueous layer was separated and extracted with EtOAc. The combined organic layers were washed with 2 N HCl, H2O, and brine. The combined organic layers were then dried over Na2SO4, filtered, and concentrated. Purification of the resulting residue by reverse phase Gilson™ HPLC (30-100% MeCN/H2O) afforded a 1:1 cis/trans mixture of the title compound as a white solid. LCMS: calculated for C25H21ClN2O3 432.89, observed m/e 432.93 M+ (Rt 2.13/4 min). 1H NMR (500 MHz, CD3OD): δ7.7.72-7.63 (m, 8H), 7.58-7.55 (m, 2H), 7.49 (d, 4H), 7.47-7.42 (m, 4H), 7.42-7.38 (m, 2H), 7.37-7.32 (m, 2H), 5.54-5.47 (m, 1H), 5.46-5.40 (m, 1H), 3.16-3.05 (m, 1H), 3.05-2.95 (m, 1H), 2.54-2.43 (m, 1H), 2.42-2.31 (m, 3H), 2.31-1.95 (m, 8H).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08895596B2
Source datasetuspto-grants-2014_11
ORD IDord-37c1793184bc4da597c70aa6f3586046
Source noteuspto-grants-2014_11